FCB Health New York’s Chief Creative Officer Kathleen Nanda sat down with PharmaLive to explore the creation of EQL Band, an innovative prototype for the world’s first smartwatch band that uses sound smart technology to accurately hear all heartbeats equally, regardless of skin tone. Kathleen weighed in on how brands can support health equity and the impact the device has had thus far.
“EQL Band is a global movement, and we are eager to engage with health tech companies, advocacy groups, and pharmaceutical companies to secure investors and partnerships for manufacturing,” Kathleen said. “Through EQL Band, we are committed to fostering dialogue among health tech companies, pharmaceutical companies, advocacy groups, and health organizations to ensure equitable smartwatch health data in clinical trials.”
